Clinical Trials

75 enrolled 9 charts

Prostatic Neoplasms

NCT04597125 2026-05-11

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

654 enrolled

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT04877522 2026-05-11

Asciminib Roll-over Study

MyeloidOther hematologic neoplasm

347 enrolled

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05201781 2026-05-08

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

295 enrolled

Plasma cell

Multiple Myeloma

NCT07030517 2026-05-08

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

75 enrolled

Plasma cell

Multiple Myeloma

NCT07176689 2026-05-08

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

50 enrolled

Sarcoma

Desmoid Tumors

NCT06274515 2026-05-06

REMERGE

320 enrolled

Breast

Breast Neoplasms

NCT07569926 2026-05-06

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

142 enrolled

Prostatic Neoplasms

NCT03173092 2026-05-04

A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Phase 4 Terminated

141 enrolled

Plasma cell

Multiple Myeloma

NCT05853458 2026-04-30

HU-F-AIM

Phase 4 Terminated

76 enrolled

Myeloid

Polycythemia Vera

NCT06752850 2026-04-30

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Classical hematologyLymphoid

37 enrolled

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT05864846 2026-04-27

EpiCom

79 enrolled

Behavior, Seizures, Tuberous Sclerosis

NCT05044819 2026-04-22

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

154 enrolled

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05457257 2026-04-21

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT03340506 2026-04-20

Dabrafenib and/or Trametinib Rollover Study

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT06952660 2026-04-20

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Gynecologic

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT06427811 2026-04-17

ASC4INDIA

MyeloidOther hematologic neoplasm

85 enrolled

Bronchiolitis Obliterans Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07221838 2026-04-09

OCTAGON

75 enrolled

Adrenal Insufficiency, Myasthenia Gravis

NCT05110196 2026-04-07

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

50 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05203172 2026-04-07

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

46 enrolled

Other solid neoplasm

Solid Tumors

NCT05631795 2026-04-07

ALPINIST

40 enrolled

Endocrine

Multiple Endocrine Neoplasia Type 1

NCT06457503 2026-04-06

TRANSPARENT

Head & Neck

Nasopharyngeal Neoplasms

NCT02584933 2026-04-02

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

233 enrolled

Tumor-Agnostic

Neoplasms

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

134 enrolled

Breast

Breast Neoplasms

NCT05252585 2026-04-02

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT05160922 2026-03-30

Crizotinib Continuation Clinical Study

LymphoidPlasma cellThoracic

27 enrolled

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT06423235 2026-03-24

ESPTTN

234 enrolled

Head & Neck

Thyroid Nodule

NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Sarcoma

NCT07486713 2026-03-20

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

CNSGastrointestinalOther hematologic neoplasm

16 enrolled

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT07279935 2026-03-19

REVIVE

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

106 enrolled

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

30 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT03573960 2026-03-06

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

50 enrolled

Head & Neck

Thyroid Neoplasms

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Carcinoma, Transitional Cell

NCT06876649 2026-03-02

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

LymphoidOther hematologic neoplasm

787 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06876662 2026-03-02

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

LymphoidOther hematologic neoplasm

279 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India